IntegraGen Logo

IntegraGen

Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.

ALINT | PA

Overview

Corporate Details

ISIN(s):
FR0010908723
LEI:
969500CQD8K0BUIGDH55
Country:
France
Address:
5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

IntegraGen, an OncoDNA group company, specializes in the genomics of cancer and rare genetic diseases. The company's mission is to translate molecular research into clinical practice through the development and commercialization of molecular diagnostic tests derived from the identification of genetic biomarkers. It provides expert genomic analysis and interpretable data services to academic researchers, private laboratories, and other life sciences organizations, aiming to advance both research and patient care.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 17:45
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 352.0 KB
2025-10-06 18:30
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 238.4 KB
2025-04-29 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 351.8 KB
2025-04-29 18:00
Earnings Release
Inside Information / News release on accounts, results
English 356.4 KB
2025-01-15 18:44
Earnings Release
Inside Information / Information on annual revenues
English 214.4 KB
2025-01-15 18:44
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 215.6 KB
2024-10-17 18:29
Earnings Release
Inside Information / News release on accounts, results
English 343.2 KB
2024-10-17 18:29
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 398.7 KB
2024-07-18 18:44
Earnings Release
Inside Information / Other news releases
English 270.7 KB
2024-07-18 18:44
Earnings Release
Informations privilégiées / Autres communiqués
French 268.3 KB
2024-04-18 18:00
Earnings Release
Inside Information / News release on accounts, results
English 372.7 KB
2024-04-18 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 419.4 KB
2024-01-16 17:45
Earnings Release
Inside Information / Information on annual revenues
English 307.9 KB
2024-01-16 17:45
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 269.3 KB
2023-10-19 18:15
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 332.6 KB

Automate Your Workflow. Get a real-time feed of all IntegraGen filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IntegraGen

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IntegraGen via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Moolec Science SA Logo
Uses Molecular Farming to grow animal proteins in plants for food, feed, and supplement industries.
United States of America MLEC
MoonLake Immunotherapeutics Logo
Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.
United States of America MLTX
Mural Oncology plc Logo
Developing cytokine-based immunotherapies for difficult-to-treat cancers and solid tumors.
United States of America MURA
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland MURA
N2OFF, Inc. Logo
Sustainable agri-tech for food preservation, emissions reduction, and renewable energy.
United States of America NITO
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571

Talk to a Data Expert

Have a question? We'll get back to you promptly.